2023

BIOEMTECH participated at Innovent Forum between 10 and 11 February weekend in Larissa as an exhibitor

Our co-founder Panagiotis Papadimitroulas with our software team members Valentina Paneta and Vassilis Eleftheriadis was there to present our machine learning and artificial intelligence tools and indicative health applications like radiomics and dosimetry. Our application specialist Sofia Lagoumtzi was there too, to present the “eyes”, our unique molecular imaging systems, and also our CRO services for preclinical testing...

The INFORM 1 Day Seminar “Advanced Computational Techniques for Oncology: Towards Explainable Artificial Intelligence”

We are pleased to announce that the Seminar’s material, including video presentations, can be downloaded at: https://lnkd.in/dVWmqS2u. Thanks to all the participants for the fruitful discussions and all the experts from LaTIM and University of Warsaw for their inspiring talks. More training events...

New paper from our US collaborators Viewpoint Molecular Targeting, Inc., who use BIOEMTECH gamma-eye to in vivo image [203Pb]Pb-PSC-PEG-T and [212Pb]Pb-PSC-PEG-T in mice.

Great images that show the accumulation on the tumors at 3h and 24h post administration, confirmed by biodistribution data at 24h. We are glad that our technology makes possible the in vivo imaging of the theragnostic pair 203Pb/212Pb, offering...

New φ-eye is here! What a beautiful system!

The last version of φ-eye is ready to be shipped for its first international destinations. Congratulations to BIOEMTECH Hardware team for adding this nice product to our portfolio. Happy to share the images from an intravenous administration of 0.1uM...

Welcome back SopHia!!!

Today we officially welcome back to the lab Sophia Sarpaki, PhD after her maternity leave. It is nice to have you back and very soon we promise that a much larger office will wait you!